BAMBI is expressed in endothelial cells and is regulated by lysosomal/autolysosomal degradation

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Xavier, Sandhya ^a   Gilbert, Victoria ^a   Rastaldi, Maria Pia ^c   Krick, Stefanie ^a   Kollins, Dmitrij ^a   Reddy, Anand ^a   Bottinger, Erwin ^a   Cohen, Clemens D ^b   Schlondorff, Detlef ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Fondazione D'Amico per la Ricerca sulle Malattie Renali   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN; BONE MORPHOGENETIC PROTEIN AND ACTIVIN MEMBRANE BOUND INHIBITOR; CELL PROTEIN; MESSENGER RNA; PROTEIN BAMBI; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; BAMBI PROTEIN, HUMAN; BAMBI PROTEIN, MOUSE; MEMBRANE PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY CELL; LYSOSOME; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; UPREGULATION; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; MOUSE MUTANT;

MURINAE;

3' UNTRANSLATED REGIONS; ANIMALS; AUTOPHAGY; CELL LINE; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; LYSOSOMES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 77958584404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012995     Document Type: Article

References (55)

1. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, et al. (1999) Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401: 480-485.
2. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332.
3. Sekiya T, Adachi S, Kohu K, Yamada T, Higuchi O, et al. (2004) Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem 279: 6840-6846.
4. Lin Z, Gao C, Ning Y, He X, Wu W, et al. (2008) The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling. J Biol Chem 283: 33053-33058.
5. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, et al. (2009) A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137: 165-175.
6. Togo N, Ohwada S, Sakurai S, Toya H, Sakamoto I, et al. (2008) Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. World J Gastroenterol 14: 4880-4888.
7. Grotewold L, Plum M, Dildrop R, Peters T, Ruther U (2001) Bambi is coexpressed with Bmp-4 during mouse embryogenesis. Mech Dev 100: 327-330.
8. Higashihori N, Song Y, Richman JM (2008) Expression and regulation of the decoy bone morphogenetic protein receptor BAMBI in the developing avian face. Dev Dyn 237: 1500-1508.
9. Tsang M, Kim R, de Caestecker MP, Kudoh T, Roberts AB, et al. (2000) Zebrafish nma is involved in TGFbeta family signaling. Genesis 28: 47-57.
10. Hwang I, Seo EY, Ha H (2009) Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res 32: 1653-1662.
11. Chen J, Bush JO, Ovitt CE, Lan Y, Jiang R (2007) The TGF-beta pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival. Genesis 45: 482-486.
12. O'Connor MN, Salles II, Cvejic A, Watkins NA, Walker A, et al. (2009) Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood 113: 4754-4762.
13. Merkel CE, Karner CM, Carroll TJ (2007) Molecular regulation of kidney development: is the answer blowing in the Wnt? Pediatr Nephrol 22: 1825-1838.
14. Zerlin M, Julius MA, Kitajewski J (2008) Wnt/Frizzled signaling in angiogenesis. Angiogenesis 11: 63-69.
15. Lin CL, Wang JY, Huang YT, Kuo YH, Surendran K, et al. (2006) Wnt/betacatenin signaling modulates survival of high glucose-stressed mesangial cells. Am Soc Nephrol 17: 2812-2820.
16. Loveland KL, Bakker M, Meehan T, Christy E, von Schonfeldt V, et al. (2003) Expression of Bambi is widespread in juvenile and adult rat tissues and is regulated in male germ cells. Endocrinology 144: 4180-4186.
17. Satriano JA, Banas B, Luckow B, Nelson P, Schlondorff DO (1997) Regulation of RANTES and ICAM-1 expression in murine mesangial cells. J Am Soc Nephrol 8: 596-603.
18. Akis N, Madaio MP (2004) Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int 65: 2223-2227.
19. Xavier S, Niranjan T, Krick S, Zhang T, Ju W, et al. (2009) TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. J Am Soc Nephrol 20: 2127-2137.
20. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, et al. (2002) Highlevel transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13: 803-813.
21. Yamawaki M, Zurbriggen A, Richard A, Vandevelde M (1993) Saponin treatment for in situ hybridization maintains good morphological preservation. J Histochem Cytochem 41: 105-109.
22. Cohen CD, Frach K, Schlondorff D, Kretzler M (2002) Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 61: 133-140.
23. Shi S, Yu L, Chiu C, Sun Y, Chen J, et al. (2008) Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 19: 2159-2169.
24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(2Delta delta C(T)) Method. Methods 24: 402-408.
25. Bottinger EP (2007) TGF-beta in renal injury and disease. Semin Nephrol 27: 309-320.
26. Bedford JJ, Leader JP, Walker RJ (2003) Aquaporin expression in normal human kidney and in renal disease. J Am Soc Nephrol 14: 2581-2587.
27. Schmid H, Henger A, Cohen CD, Frach K, Grone HJ, et al. (2003) Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 14: 2958-2966.
28. Schlondorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20: 1179-1187.
29. Mundel P, Reiser J, Zuniga Mejia BA, Pavenstadt H, Davidson GR, et al. (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258.
30. Wolf G, Mueller E, Stahl RA, Ziyadeh FN (1993) Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 92: 1366-1372.
31. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanabe M, et al. (1988) Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107: 1359-1368.
32. Edgell CJ, McDonald CC, Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 80: 3734-3737.
33. Sekiya T, Oda T, Matsuura K, Akiyama T (2004) Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling. Biochem Biophys Res Commun 320: 680-684.
34. Barreau C, Paillard L, Osborne HB (2005) AU-rich elements and associated factors: are there unifying principles? Nuc Acids Res 33: 7138-7150.
35. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, et al. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A 96: 10403-10408.
36. Klionsky DJ, Elazar Z, Seglen PO, Rubinsztein DC (2008) Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy 4: 849-950.
37. Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y (1991) Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 266: 17707-17712.
38. Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelarova H, Meijer AJ (1997) The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 243: 240-246.
39. Seglen PO, Gordon PB (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 79: 1889-1892.
40. Mizushima N (2004) Methods for monitoring autophagy. Int J Biochem Cell Biol 36: 2491-2502.
41. Raught B, Gingras AC, Sonenberg N (2001) The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A 98: 7037-7044.
42. Schroder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789.
43. Xu C, Bailly-Maitre B, Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115: 2656-2664.
44. Knight C, Simmons D, Gu TT, Gluhak-Heinrich J, Pavlin D, et al. (2001) Cloning, characterization, and tissue expression pattern of mouse Nma/BAMBI during odontogenesis. J Dent Res 80: 1895-1902.
45. Gazit D, Ebner R, Kahn AJ, Derynck R (1993) Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol 7: 189-198.
46. Woodward TL, Dumont N, O'Connor-McCourt M, Turner JD, Philip A (1995) Characterization of transforming growth factor-beta growth regulatory effects and receptors on bovine mammary cells. J Cell Physiol 165: 339-348.
47. El Achkar TM, Huang X, Plotkin Z, Sandoval RM, Rhodes GJ, et al. (2006) Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am J Physiol Renal Physiol 290: F1034-F1043.
48. Hao S, Baltimore D (2009) The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 10: 281-288.
49. Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075.
50. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, et al. (2009) Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461: 654-658.
51. Finn PF, Mesires NT, Vine M, Dice JF (2005) Effects of small molecules on chaperone-mediated autophagy. Autophagy 1: 141-145.
52. Rote KV, Rechsteiner M (1983) Degradation of microinjected proteins: effects of lysosomotropic agents and inhibitors of autophagy. J Cell Physiol 116: 103-110.
53. Hayes S, Chawla A, Corvera S (2002) TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 158: 1239-1249.
54. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, et al. (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6: 1365-1375.
55. Neusser MA, Lindenmeyer MT, Moll AG, Segerer S, Edenhofer I, et al. (2010) Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol 176(2): 594-607.